# Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma

> **NCT07144657** · PHASE2 · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- MALT Lymphoma of Stomach

## Interventions

- **DRUG:** Esomeprazole, Bismuth tripotassium dicitrate, Tetracycline, and Metronidazole

## Key facts

- **NCT ID:** NCT07144657
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144657, "Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07144657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*